Figure 2.
Survival curves of patient subgroups according to prognostic factors. (A) Patients with different primary sites (P<0.0001). (B) Patients with synchronous or metachronous disease (P=0.008). (C) Patients with or without disease beyond the ovary (P=0.0138). (D) Patients with or without ascites (P<0.0001). (E) Patients with or without chemotherapy (P=0.0796). (F) Patients with or without metastasectomy (P=0.0060).
